Cancer Nanotechnology

Journal Title：Cancer Nanotechnology

Aim:

Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas.

Scope:

Articles describing original research in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis and treatment of cancer (open submission process). Review, editorial and tutorial articles picking up on subthemes of emerging importance where nanostructures and the induction of nanoscale processes are used for the prevention, diagnosis and treatment of cancer.

目的：

認識到癌癥是一組由納米結構問題（即 DNA）引起的疾病，并且認識到涉及納米級結構和過程的治療方法具有獨特的優勢，因此《癌癥納米技術》雜志旨在傳播前沿研究；促進使用納米結構和誘導納米級過程預防、診斷和治療癌癥的新興趨勢；并涵蓋相關輔助領域。

范圍：

描述使用納米結構和誘導納米級過程預防、診斷和治療癌癥的原創研究的文章（開放提交流程）。評論、編輯和教程文章，重點介紹新興重要子主題，其中納米結構和誘導納米級過程用于預防、診斷和治療癌癥。

Cancer Nanotechnology創刊于2010年，由Springer Vienna出版商出版，收稿方向涵蓋Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science全領域，此刊是該細分領域中屬于非常不錯的SCI期刊，在行業細分領域中學術影響力較大，專業度認可很高，所以對原創文章要求創新性較高，如果您的文章質量很高，可以嘗試。平均審稿速度 15 Weeks ，影響因子指數4.5，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。